Monthly
US$200
Billed every month
Memantine Hydrochloride Tablets(盐酸美金刚片)
Companies, stages and changes, with each record available on this page.
No changes recorded by this site in the last 90 days
Complete CDE snapshot: 2026/11/10 07:27
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders29View records ↓
Under-review filings2View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers34View records ↓
API companies with A status37View records ↓
Chemical-drug catalogue
Loaded records: 29 holders; 1 in the quality-and-efficacy consistency-evaluation category, and 26 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 云鹏医药集团有限公司 | 云鹏医药集团有限公司 | 国药准字H20256103 | 2025/12/03 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川尚锐生物医药有限公司 | 成都通德药业有限公司 | 国药准字H20255741 | 2025/10/21 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 岳阳新华达制药有限公司 | 岳阳新华达制药有限公司 | 国药准字H20255692 | 2025/10/14 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都百裕制药股份有限公司 | 四川宏明博思药业有限公司 | 国药准字H20249194 | 2024/10/29 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南林恒制药股份有限公司 | 海南林恒制药股份有限公司 | 国药准字H20244956 | 2024/09/19 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西天地人和药业有限公司 | 银谷制药有限责任公司 | 国药准字H20244658 | 2024/08/20 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西天地人和药业有限公司 | 银谷制药有限责任公司 | 国药准字H20244659 | 2024/08/20 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新华制药股份有限公司 | 哈尔滨圣泰生物制药有限公司 | 国药准字H20243056 | 2024/01/16 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海上药中西制药有限公司 | 上海上药中西制药有限公司 | 国药准字H20234004 | 2023/08/01 | 20mg | Not stated by source | CDE |
| 上海上药中西制药有限公司 | 上海上药中西制药有限公司 | 国药准字H20234003 | 2023/08/01 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福安药业集团庆余堂制药有限公司 | 福安药业集团庆余堂制药有限公司 | 国药准字H20233592 | 2023/05/26 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南涛生医药科技研究院有限公司 | 南京海纳制药有限公司 | 国药准字H20233545 | 2023/05/12 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川新斯顿制药股份有限公司 | 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 2023/03/07 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| Dr. Reddy’s Laboratories Limited | Dr. Reddy’s Laboratories Limited | 国药准字HJ20220092 | 2022/11/22 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 保定天浩制药有限公司 | 保定天浩制药有限公司 | 国药准字H20223855 | 2022/11/15 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽金太阳生化药业有限公司 | 安徽金太阳生化药业有限公司 | 国药准字H20223816 | 2022/11/08 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽金太阳生化药业有限公司 | 安徽金太阳生化药业有限公司 | 国药准字H20223817 | 2022/11/08 | 15mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽金太阳生化药业有限公司 | 安徽金太阳生化药业有限公司 | 国药准字H20223815 | 2022/11/08 | 5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽金太阳生化药业有限公司 | 安徽金太阳生化药业有限公司 | 国药准字H20223818 | 2022/11/08 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京瑞捷医药科技有限公司 | 浙江杭康药业有限公司 | 国药准字H20223585 | 2022/08/10 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天地恒一制药股份有限公司 | 天地恒一制药股份有限公司 | 国药准字H20223406 | 2022/06/16 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波双成药业有限公司 | 宁波双成药业有限公司 | 国药准字H20213930 | 2021/12/08 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波双成药业有限公司 | 宁波双成药业有限公司 | 国药准字H20213931 | 2021/12/08 | 5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 赤峰赛林泰药业有限公司 | 赤峰赛林泰药业有限公司 | 国药准字H20213729 | 2021/09/13 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20213657 | 2021/08/25 | 10mg | Not stated by source | CDE |
| 长春海悦药业股份有限公司 | 长春海悦药业股份有限公司 | 国药准字H20213596 | 2021/07/20 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 珠海联邦制药股份有限公司中山分公司 | 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 2021/05/21 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H20213119 | 2021/02/02 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 普洛药业股份有限公司 | 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 2021/01/30 | 10mg | Not stated by source | CDE |
| 合肥合源药业有限公司 | 合肥合源药业有限公司 | 国药准字H20203555 | 2020/11/04 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 扬子江药业集团北京海燕药业有限公司 | 扬子江药业集团有限公司 | 国药准字H20203349 | 2020/07/21 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20203320 | 2020/07/16 | 5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20203319 | 2020/07/16 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽华辰制药有限公司 | 安徽华辰制药有限公司 | 国药准字H20203134 | 2020/03/31 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南洞庭药业股份有限公司 | 湖南洞庭药业股份有限公司 | 国药准字H20203016 | 2020/01/21 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 2019/09/17 | 10mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 34 distinct approval numbers and 29 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 10mg | Category B (乙) | XN06DXM045A001010100381 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010100600 | NHSA |
| 上海上药中西制药有限公司 | 国药准字H20234003 | 10mg | Category B (乙) | XN06DXM045A001010100834 | NHSA |
| 扬子江药业集团有限公司 | 国药准字H20203349 | 10mg | Category B (乙) | XN06DXM045A001010101749 | NHSA |
| 重庆锐恩医药有限公司 | 国药准字H20233592 | 10mg | Category B (乙) | XN06DXM045A001010101877 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 10mg | Category B (乙) | XN06DXM045A001010102273 | NHSA |
| 保定天浩制药有限公司 | 国药准字H20223855 | 10mg | Category B (乙) | XN06DXM045A001010102551 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20203320 | 5mg | Category B (乙) | XN06DXM045A001010102770 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20256103 | 10mg | Category B (乙) | XN06DXM045A001010102968 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213596 | 10mg | Category B (乙) | XN06DXM045A001010103307 | NHSA |
| 赤峰赛林泰药业有限公司 | 国药准字H20213729 | 10mg | Category B (乙) | XN06DXM045A001010103865 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010104152 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20243056 | 10mg | Category B (乙) | XN06DXM045A001010104187 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010104311 | NHSA |
| 南京瑞捷医药科技有限公司 | 国药准字H20223585 | 10mg | Category B (乙) | XN06DXM045A001010104642 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20213657 | 10mg | Category B (乙) | XN06DXM045A001010104647 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 10mg | Category B (乙) | XN06DXM045A001010104685 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H20203016 | 10mg | Category B (乙) | XN06DXM045A001010104917 | NHSA |
| 岳阳新华达制药有限公司 | 国药准字H20255692 | 10mg | Category B (乙) | XN06DXM045A001010104918 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20244956 | 10mg | Category B (乙) | XN06DXM045A001010105792 | NHSA |
| 成都百裕制药股份有限公司 | 国药准字H20249194 | 10mg | Category B (乙) | XN06DXM045A001010106725 | NHSA |
| 安徽华辰制药有限公司 | 国药准字H20203134 | 10mg | Category B (乙) | XN06DXM045A001010107535 | NHSA |
| 合肥合源药业有限公司 | 国药准字H20203555 | 10mg | Category B (乙) | XN06DXM045A001010109541 | NHSA |
| Dr.Reddy's Laboratories Limited | 国药准字HJ20220092 | 10mg | Category B (乙) | XN06DXM045A001010178377 | NHSA |
| H. Lundbeck A/S | 国药准字HJ20120268 | 10mg | Category B (乙) | XN06DXM045A001010178996 | NHSA |
| 天地恒一制药股份有限公司 | 国药准字H20223406 | 10mg | Category B (乙) | XN06DXM045A001010180086 | NHSA |
| 四川尚锐生物医药有限公司 | 国药准字H20255741 | 10mg | Category B (乙) | XN06DXM045A001010183737 | NHSA |
| 山西同达药业有限公司 | 国药准字H20213930 | 10mg | Category B (乙) | XN06DXM045A001010183935 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263414 | 10mg | Category B (乙) | XN06DXM045A001010184621 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 10mg | Category B (乙) | XN06DXM045A001010200381 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010200600 | NHSA |
| 重庆锐恩医药有限公司 | 国药准字H20233592 | 10mg | Category B (乙) | XN06DXM045A001010201877 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 10mg | Category B (乙) | XN06DXM045A001010202273 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213596 | 10mg | Category B (乙) | XN06DXM045A001010203307 | NHSA |
| 赤峰赛林泰药业有限公司 | 国药准字H20213729 | 10mg | Category B (乙) | XN06DXM045A001010203865 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010204152 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010204311 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20213657 | 10mg | Category B (乙) | XN06DXM045A001010204647 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 10mg | Category B (乙) | XN06DXM045A001010204685 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H20203016 | 10mg | Category B (乙) | XN06DXM045A001010204917 | NHSA |
| 岳阳新华达制药有限公司 | 国药准字H20255692 | 10mg | Category B (乙) | XN06DXM045A001010204918 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20244956 | 10mg | Category B (乙) | XN06DXM045A001010205792 | NHSA |
| 成都百裕制药股份有限公司 | 国药准字H20249194 | 10mg | Category B (乙) | XN06DXM045A001010206725 | NHSA |
| H.Lundbeck A/S | H20130372 | 10mg | Category B (乙) | XN06DXM045A001010278996 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263414 | 10mg | Category B (乙) | XN06DXM045A001010284621 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 10mg | Category B (乙) | XN06DXM045A001010300381 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010300600 | NHSA |
| 重庆锐恩医药有限公司 | 国药准字H20233592 | 10mg | Category B (乙) | XN06DXM045A001010301877 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 10mg | Category B (乙) | XN06DXM045A001010302273 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213596 | 10mg | Category B (乙) | XN06DXM045A001010303307 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010304152 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010304311 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20213657 | 10mg | Category B (乙) | XN06DXM045A001010304647 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 10mg | Category B (乙) | XN06DXM045A001010304685 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20244956 | 10mg | Category B (乙) | XN06DXM045A001010305792 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263414 | 10mg | Category B (乙) | XN06DXM045A001010384621 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 10mg | Category B (乙) | XN06DXM045A001010400381 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010400600 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 10mg | Category B (乙) | XN06DXM045A001010402273 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010404152 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010404311 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20213657 | 10mg | Category B (乙) | XN06DXM045A001010404647 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 10mg | Category B (乙) | XN06DXM045A001010404685 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263414 | 10mg | Category B (乙) | XN06DXM045A001010484621 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20193268 | 10mg | Category B (乙) | XN06DXM045A001010500381 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010500600 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20233256 | 10mg | Category B (乙) | XN06DXM045A001010502273 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010504152 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010504311 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20213657 | 10mg | Category B (乙) | XN06DXM045A001010504647 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20213080 | 10mg | Category B (乙) | XN06DXM045A001010504685 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010600600 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20213119 | 10mg | Category B (乙) | XN06DXM045A001010604152 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010604311 | NHSA |
| 珠海联邦制药股份有限公司中山分公司 | 国药准字H20130086 | 10mg | Category B (乙) | XN06DXM045A001010700600 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010704311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223815 | 5mg | Category B (乙) | XN06DXM045A001010804311 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20203319 | 10mg | Category B (乙) | XN06DXM045A001020102770 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020104311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020204311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020304311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020404311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020504311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020604311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020704311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223816 | 10mg | Category B (乙) | XN06DXM045A001020804311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030104311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030204311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030304311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030404311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030504311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030604311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030704311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223817 | 15mg | Category B (乙) | XN06DXM045A001030804311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040104311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040204311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040304311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040404311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040504311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040604311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040704311 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20223818 | 20mg | Category B (乙) | XN06DXM045A001040804311 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 2 filings and 2 distinct first applicants.
Generic 2
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
API registrations
Non-component matches: 37 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 盐酸美金刚 | OLON S.p.A. | Y20240001170 | A | Exact ingredient | 2026/09/01 | CDE |
| 盐酸美金刚 | 万洋衡水制药有限公司 | Y20240000483 | A | Exact ingredient | 2025/12/18 | CDE |
| 盐酸美金刚 | 沈阳天邦药业有限公司 | Y20230001221 | A | Exact ingredient | 2025/11/19 | CDE |
| 盐酸美金刚 | 云鹏医药集团有限公司 | Y20230001198 | A | Exact ingredient | 2025/11/26 | CDE |
| 盐酸美金刚 | 安徽普利药业有限公司 | Y20230000102 | A | Exact ingredient | 2024/09/10 | CDE |
| 盐酸美金刚 | 植恩生物技术股份有限公司 | Y20220000214 | A | Exact ingredient | 2023/12/05 | CDE |
| 盐酸美金刚 | COHANCE LIFESCIENCES LIMITED | Y20210000513 | A | Exact ingredient | 2025/06/03 | CDE |
| 盐酸美金刚 | 山东海佑福瑞达制药有限公司 | Y20210000467 | A | Exact ingredient | 2026/03/18 | CDE |
| 盐酸美金刚 | 安徽美诺华药物化学有限公司 | Y20210000550 | A | Exact ingredient | 2026/01/01 | CDE |
| 盐酸美金刚 | Unichem Laboratories Limited | Y20210000402 | A | Exact ingredient | 2023/08/11 | CDE |
| 盐酸美金刚 | 万特制药（海南）有限公司 | Y20200001047 | A | Exact ingredient | 2022/10/28 | CDE |
| 盐酸美金刚 | 浙江尚泰生物制药有限公司 | Y20200001118 | A | Exact ingredient | 2026/09/17 | CDE |
| 盐酸美金刚 | Dr.Reddy's Laboratories Ltd. | Y20200000988 | A | Exact ingredient | 2023/05/01 | CDE |
| 盐酸美金刚 | 四川伊诺达博医药科技有限公司 | Y20200001003 | A | Exact ingredient | 2023/07/24 | CDE |
| 盐酸美金刚 | 苏州第四制药厂有限公司 | Y20190021531 | A | Exact ingredient | 2023/07/28 | CDE |
| 盐酸美金刚 | Matrix Pharmacorp Private Limited | Y20190001079 | A | Exact ingredient | 2026/05/20 | CDE |
| 盐酸美金刚 | 珠海联邦制药股份有限公司 | Y20190007101 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸美金刚 | 湖南洞庭药业股份有限公司 | Y20190006826 | A | Exact ingredient | — | CDE |
| 盐酸美金刚 | 绍兴京新药业有限公司 | Y20190006801 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸美金刚 | 浙江华海药业股份有限公司 | Y20190000580 | A | Exact ingredient | 2026/06/12 | CDE |
| 盐酸美金刚 | 合肥合源药业有限公司 | Y20190000706 | A | Exact ingredient | 2025/06/25 | CDE |
| 盐酸美金刚 | 浙江普洛康裕制药有限公司 | Y20190000110 | A | Exact ingredient | 2025/07/29 | CDE |
| 盐酸美金刚 | UNION QUIMICO FARMACEUTICA, SA (UQUIFA) | Y20190000047 | I | Exact ingredient | 2019/03/13 | CDE |
| 盐酸美金刚 | MSN Pharmachem Private Limited | Y20180001481 | A | Exact ingredient | 2025/06/17 | CDE |
| 盐酸美金刚 | 安徽华辰制药有限公司 | Y20180000939 | A | Exact ingredient | 2025/01/18 | CDE |
| 盐酸美金刚 | 山东罗欣药业集团恒欣药业有限公司 | Y20170002157 | I | Exact ingredient | — | CDE |
| 盐酸美金刚 | Hetero Drugs Limited (Unit-IX) | Y20170001630 | A | Exact ingredient | 2023/02/17 | CDE |
| 盐酸美金刚 | 广州白云山医药集团股份有限公司白云山化学制药厂 | Y20170001443 | A | Exact ingredient | 2024/06/06 | CDE |
| 盐酸美金刚 | 海南普利制药股份有限公司 | Y20170001437 | A | Exact ingredient | 2022/10/19 | CDE |
| 盐酸美金刚 | 瑞阳制药股份有限公司 | Y20170001394 | A | Exact ingredient | 2024/01/03 | CDE |
| 盐酸美金刚 | 山东方明药业集团股份有限公司 | Y20170001383 | A | Exact ingredient | 2024/08/03 | CDE |
| 盐酸美金刚 | 南京正大天晴制药有限公司 | Y20170001374 | I | Exact ingredient | — | CDE |
| 盐酸美金刚 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20170001336 | A | Exact ingredient | 2023/08/11 | CDE |
| 盐酸美金刚 | 安徽金太阳生化药业有限公司 | Y20170001330 | A | Exact ingredient | 2024/12/18 | CDE |
| 盐酸美金刚 | 长春海悦药业股份有限公司 | Y20170001254 | A | Exact ingredient | 2023/10/27 | CDE |
| 盐酸美金刚 | 山东罗欣药业集团恒欣药业有限公司 | Y20170001145 | A | Exact ingredient | 2024/11/29 | CDE |
| 盐酸美金刚 | MEGAFINE PHARMA (P) LTD. | Y20170001045 | A | Exact ingredient | 2024/12/11 | CDE |
| 盐酸美金刚 | Alembic Pharmaceuticals Limited | Y20170000855 | A | Exact ingredient | 2024/11/07 | CDE |
| 盐酸美金刚 | TAPI Croatia Industries Ltd. | Y20170000828 | A | Exact ingredient | 2025/06/11 | CDE |
| 盐酸美金刚 | 江苏奥赛康药业股份有限公司 | Y20170000703 | I | Exact ingredient | — | CDE |
| 盐酸美金刚 | AMSA-ANONIMA MATERIE SINTETICHE & AFFINI S.P.A. | Y20170000608 | A | Exact ingredient | 2025/04/29 | CDE |
| 盐酸美金刚 | 海南惠普森医药生物技术有限公司 | Y20170000427 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Memantine Hydrochloride Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy